1 / 11

Cooperation in oral anticoagulant therapy

Cooperation in oral anticoagulant therapy. needs and barriers to improve H. Drewes, M. Lambooij, C. Baan , B. Meijboom, G. Westert. Oral anticoagulant therapy (OAT). OAT reduce the risk of thrombosis Challenge: balance the risk between haemoraghe and thrombosis

bell-roberson
Download Presentation

Cooperation in oral anticoagulant therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cooperation in oral anticoagulant therapy needs and barriers to improve H. Drewes, M. Lambooij, C. Baan, B. Meijboom, G. Westert

  2. Oral anticoagulant therapy (OAT) OAT reduce the risk of thrombosis • Challenge: balance the risk between haemoraghe and thrombosis • Balance influenced by many factors • e.g. co-medication, fever, food intake, doses advices • Balance influenced by many health care professionals  Cooperation needed • No. of patients in NL: 350.000 • 25% of avoidable hospitalizations related to OAT

  3. Anticoagulant clinics (AC) • In Netherlands 59 anticoagulant clinics (ACs): monitoring patients and advice on medication use • ACs provide better patient outcomes than routine medical care However: • Substantial differences in patient outcomes between ACs • Differences in cooperation between ACs • e.g. multidisciplinary protocols, structural meetings etc.

  4. Research questions To identify the bottlenecks for cooperation To identify facilitators/solutions to improve cooperation To identify barriers for improvement the cooperation

  5. Methods • Data • 23 specialised anticoagulant clinics (AC) • selective purposive sampling based on 3 characteristics: • the number of patients • the organisation structure • quality of care considering the patient outcomes • 68 semi-structured interviews

  6. Methods Data analysis • Fully transcriped interviews open coded by two authors • data structured with Chronic Care Model

  7. Experienced bottlenecks • Lack of knowledge: Although a patient was stable with 6 tablets a day, he was discharged with a doses of 4, 2, 2, for the following three days. [..]You could say, ask the patient what he usually used. • Lack of consensus between professionals We don’t agree with the policy of one of our hospitals, but couldn’t convince them. We have to follow their advice; otherwise patients are send home without an operation. • Limited information exchange Really, it is sometime a struggle to get the information about a hospital admission.

  8. Experienced bottlenecks Bottlenecks leads to: - Suboptimal OAT - Inefficacy due to time-consuming effort to correct mistakes

  9. Preferred initiatives

  10. Major Experienced barriers • Lack of motivation • professionals not motivated to learn from ACs (no knowledge) • don’t accept their view (no consensus) • are not motivated to inform the ACs (no information). Lack of time • Lack of resources/ materials

  11. Conclusions • Bottlenecks of coordination are information exchange, lack of knowledge, lack of consensus • Decision support is prerequisite for the succes of AC management as it improves knowledge • Crucial to succesfully implement decision support seems to be informal coordination/contact

More Related